Medtric Biotech
Team Bios
Team Bios
Sean Connell, PhD: President and COO
He is the co-inventor and has over 7 years experience in biomedical engineering research. He has published six papers and has co-authored a book chapter on advanced tissue engineering. He received his B.S. in engineering from Georgia Institute of Technology and is receiving his PhD in biomedical engineering from Purdue University.
Jianming Li, PhD: Chief Scientific Officer
Dr. Li is an expert in biomaterials. He has published 12 peer-reviewed journal articles and is the leading author of two book chapters in the area of biomaterials. Dr. Li’s research has been highlighted in several media outlets including The Guardian Newspaper in the UK. Jianming has further conducted international research at leading Chinese institutions. Jianming was a Henry Ford scholar and received the prestigious Chorafas prize in 2008. Dr. Li received his PhD from Purdue in biomedical engineering and his bachelor’s degree from University of Michigan in mechanical engineering.
Robert Einterz, MBA: VP of Business Development
He earned his bachelor’s degree in Chemistry and French from Hanover College in 2006. He has consulted for various start-up related institutions including In-Vivo Ventures, SciSyn Pharmaceuticals, and Purdue’s Office of Technology Commercialization. He will receive his MBA from Purdue University’s Krannert School of Management in 2011.
Business Summary
Medtric Biotech’s cornerstone technology is OSMOSETM - a unique method of destroying bacteria for the prevention and treatment of infected wounds. OSMOSETM represents a new class of antimicrobial wound dressings that relies on a physical mechanism for eliminating bacteria. Medtric’s approach offers three competitive advantages: (i) effective against a wide array of bacteria - even antibiotic resistant strains, (ii) promotes healing and (iii) a low-cost solution in a high-priced field. Medtric was founded in 2010 on a vision to deliver clinically robust and economically sensible wound care.